Gilead Sciences Inc (NAS:GILD)
$ 67.9 0.18 (0.27%) Market Cap: 84.59 Bil Enterprise Value: 104.85 Bil PE Ratio: 188.61 PB Ratio: 4.83 GF Score: 74/100

Gilead Sciences Inc at Bank of America Healthcare Conference Transcript

May 10, 2022 / 09:00PM GMT
Release Date Price: $61.78 (+0.16%)
Geoffrey Christopher Meacham
BofA Securities, Research Division - Research Analyst

Sessions of the Bank of America Healthcare Conference. So my name is Geoff Meacham. I'm the senior biopharma analyst here. And my colleague, Jason Zemansky, is with me on stage as well. And we're thrilled to have Andy Dickinson today, who is CFO of Gilead Sciences. Andy?

Andrew D. Dickinson
Gilead Sciences, Inc. - Executive VP & CFO

Thank you. Thanks. I'm thrilled to be here. Thank you for having us.

Questions & Answers

Geoffrey Christopher Meacham
BofA Securities, Research Division - Research Analyst

Yes. Just to kick it off, following the quarter, there's a lot of questions we get, Andy, about a lot of the puts and takes in the P&L from the R&D expenses that are now included, some of the changes to repatriation tax. I want to get maybe a high-level view of all the puts and takes from a P&L and a cash perspective for Gilead, and then we can get into sort of the strategy kind of questions on some of the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot